Mountains

Clear thinking,
straight talking

Clear thinking,
straight talking

River Thames and St Pauls

Trusted partner to businesses
with big ambitions

Trusted partner to businesses
with big ambitions

Bank of England

Full service
investment bank

Full service
investment bank

Fund raise

Northland Capital Partners has acted as Joint Broker in a £10,000,000 placing for Motif Bio (MTFB.L). The majority of the funds raised will be used to fund near term regulatory and pre-commercial investments for iclaprim, the Company’s novel antibiotic candidate

Fund raise

Northland Capital Partners has acted as Nomad and Sole Broker in a £740,000 placing for Edenville Energy (EDL.L). The majority of the funds raised will be deployed on expenditure, primarily capital expenditure, in connection with the expansion and enhancement of Edenville’s current mining activities.

Polarean Imaging – IPO

Northland Capital Partners is pleased to announce that Polarean Imaging (POLX.L) has listed on AIM raising £3m. Polarean is a revenue generating, medical drug-device combination company operating in the high resolution medical imaging market. Net proceeds of the Placing are expected to be used for the Company’s Phase III clinical trials to gain clearance to market hyperpolarised Xenon gas (129Xe) as a contrast agent and the polariser as a device.

We are moving

Northland Capital Partners Limited is pleased to inform you that we will be moving to new offices with effect from Monday 12 March 2018.   The new address is: 40 Gracechurch Street, London, EC3V 0BT

 Our new offices are conveniently and centrally located in the heart of the City of London and are a short walk from both Bank Station and Monument .

 Please note that our telephone numbers will not change.

 We look forward to seeing you in our new offices soon

 

Fund raise

Northland Capital Partners has acted as Nomad and Sole Broker in a £1,300,000 placing for Fishing Republic (FISH.L). Fishing Republic will be used to further advance and develop the Company’s e-commerce operations, logistics and merchandising activities following the recent review of operations. It will also be used to provide additional working capital to accelerate the rate of growth of online sales.

Fund raise

Northland Capital Partners has acted as Nomad and Sole Broker in a £10,000,000 placing for ImmuPharma (IMM.L). ImmuPharma will apply these additional funds to support future investment in ImmuPharma’s P140 peptide platform. The proceeds of the Placing will also provide the Company with additional working capital.

Scroll Up